Article Versions Notes

Mele V, Basso C, Governa V, Glaus Garzon JF, Muraro MG, Däster S, Nebiker CA, Mechera R, Bolli M, Schmidt A, et al. Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells. Cancers. 2022; 14(8):2024. https://doi.org/10.3390/cancers14082024

Mele, Valentina, Camilla Basso, Valeria Governa, Jesus F. Glaus Garzon, Manuele G. Muraro, Silvio Däster, Christian A. Nebiker, Robert Mechera, Martin Bolli, Alexander Schmidt, and et al. 2022. "Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells" Cancers 14, no. 8: 2024. https://doi.org/10.3390/cancers14082024

Mele, V., Basso, C., Governa, V., Glaus Garzon, J. F., Muraro, M. G., Däster, S., Nebiker, C. A., Mechera, R., Bolli, M., Schmidt, A., Geiger, R., Spagnoli, G. C., Christoforidis, D., Majno, P. E., Borsig, L., & Iezzi, G. (2022). Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells. Cancers, 14(8), 2024. https://doi.org/10.3390/cancers14082024